We hear you! Your pharmacy workplace is stressed and stretched. You have rapidly growing concerns for patient safety. Still, you are there—every day—to care for your patients despite conditions that seem to be working against you.

WASHINGTON, DC –  Today, the American Pharmacists Association (APhA) released the results of a new analysis showing that underserved and vulnerable communities do not have equitable access to care from COVID-19 Test to Treat sites, including lifesaving COVID-19 oral antivirals.

A study in JAMA Network Open found that pharmacists can play a key role in enhancing antimicrobial prescribing during transitions of care.

CDC recently approved new pneumococcal vaccine (PCV) recommendations. Now, CDC recommends the use of either 20-valent pneumococcal conjugate vaccine (PCV20) alone or 15-valent pneumococcal conjugate vaccine (PCV15) in series with 23-valent pneumococcal polysaccharide vaccine (PPSV23) for all adults aged 65 years or older and for adults aged 19 to 64 years with certain underlying medical conditions or other risk factors who have not previously received a PCV vaccine or whose previous vaccination history is unknown.